Details for 2019845789
Up to date per 01.04.2026
Actions
Details for 2019845789
Granted/Registered
European Patent
27.10.2021 A
18.10.2023 B1
18.12.2018
US
201862781380 P
C12N 15/55 20060101AFI20200701BHEP
Owner
Ultragenyx Pharmaceutical Inc.60 Leveroni Court Novato, CA 94949US
Representative
Representative
Dipl.-Ing. Dr. techn. Gerda RedlDonau-City-Straße 111220 WIENAT
Inventor
TIPPER, Christopher Novato, CA 94949US
CLARK, Kelly Reed Novato, CA 94949US
WADSWORTH, Samuel Novato, CA 94949US
Information about Fees